Cumulus (Devices and Supplies)

The AI engine Fit Assessment

Beta

The company will be attending the 2024 Health Tech Forward Event

Blurb

Cumulus Neuroscience has created a next-generation integrated physiological and digital biomarker platform.

HQ Location

United Kingdom

Founded

2015

Employees

11 - 50

Total funding raised

$11.14M

Last Funding Event

Grant, $1.55M, July 11, 2024

Smart insights

  • Catherine Msc (Chief People Officer) worked at Lilium as Head of People Business Partnering for 1.5 years (2021 - 2022)
  • Val Miftakhov (Founder & CEO) worked at Google in various roles, including Head of R&D, Google for Work Incubation, for a total of 4 years (2012 - 2016)
  • 6m headcount growth: 25%
  • 1Y headcount growth: 94%
  • Headcount-to-last-round ratio: 5.3 employees/$M

Developer of a data-centric brain health tracking technology designed to make simple lifestyle changes to encourage healthy aging of the human brain. The company's technology is a wearable device that pairs with a user's smartphone and monitors their brain activity while they play games on the application and offers brain imaging and insights about the effects or impacts of sleep and other training and lifestyle factors on the short and long-term cognitive health of the players, enabling patients to battle dementia and medical professionals to solve healthcare challenges in neurodegeneration and psychiatry.